47°F
Sponsored by

Mercy Tests Out Dissolvable Device to Treat Heart Disease

SPRINGFIELD, Mo. -- Hospital officials announced Mercy is the only facility in the region offering a trial of "absorb," a temporary mesh tube made of material commonly used in dissolvable stitches.
SPRINGFIELD, Mo. -- Mercy Springfield is testing out a new dissolvable device to help treat heart failure.

In a news release Friday, hospital officials announced Mercy is the only facility in the region offering a trial of "absorb," a temporary mesh tube made of material commonly used in dissolvable stitches.

The goal is to fight coronary artery disease by clearing up blockage in blood vessels. Right now, doctors typically use balloon angioplasty or metallic and drug eluting stents to restore blood flow.

Absorb, referred to as a bioresorbable vascular scaffold (BVS) that evaporates from the body. It leaves behind tiny markers to help doctors know where it was previously place.

"Since there isn't a metal stent left behind, patients who need treatment in the future can get another stent," writes Dr. Robert Merritt, Mercy cardiologist and the site's principal investigator in the trial. "Right now, a patient with several metal stents in one area of an artery may have no choice but open heart surgery."

Mercy says this is a randomized study, so patients don't know if they are receiving a metal stent or the new Absorb scaffold. The trial will enroll approximately 2,250 patients, and researchers will determine the safety and effectiveness of the Absorb BVS, as well as how much natural motion may return to the vessel after the stent dissolves.

Absorb was developed by Abbott, which is the first company in the world to begin testing a bioresorbable vascular scaffold in patients in the United States. If you are interested in participating in the study, please call Mercy Medical Research Institute at (417) 841-0250.


Information courtesy: Mercy Springfield
Page: [[$index + 1]]
comments powered by Disqus